CobiCure is pursuing a non-profit approach to the development of cardiac devices for underserved patient populations.
Money talks when it comes to medtech, and to develop a commercially successful device, its target population must be either large or valuable – often a combination of both. CobiCure, a non-profit founded by the Advancium Health Network, hopes to defy this trend by working to address unmet needs in the treatment of congenital cardiac disorders.
The Advancium Health Network is an independent public charity originally established by Deerfield Management and the Deerfield Foundation.
Philips says the expansion of its facility in Reedsville, PA, will not only boost its capacity to produce AI-enabled ultrasounds that are used in hospitals across the US but will also create 120 well-paying jobs.
The US FDA issued a pair of early alerts on Wednesday warning customers about serious adverse events associated with two Boston Scientific cardiac devices. Both alerts include numerous reports of injuries and deaths and are part of the FDA’s ongoing pilot to enhance its recall process.
Ultromics has secured $55m in Series C funding to advance its AI tool, EchoGo, which detects undiagnosed heart failure. The company's focus on diseases with available treatments resonated with investors.
Agent drug coated balloon, Watchman product sales, and electrophysiology (EP) business unit growth offset Acurate discontinuation and tariff headwinds. CEO Michael Mahoney shouted out coronary therapies business and answered questions on CMS proposed Ambulatory Surgical Center codes.
